Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials

Ruth H. Keogh*, Rebecca Cosgriff, Eleni Rosalina Andrinopoulou, Keith G. Brownlee, Siobhán B. Carr, Karla Diaz-Ordaz, Emily Granger, Nicholas P. Jewell, Alex Lewin, Clemence Leyrat, Daniela K. Schlüter, Maarten van Smeden, Rhonda D. Szczesniak, Gary J. Connett

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
3 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science